Published in Medical Devices and Surgical Technology Week, October 16th, 2005
In a recent study, physicians in the United States "assessed the psychometric properties of a recently developed health-related quality of life (HRQOL) instrument (Vecu et Sante Perque de l'Adolescent-Malade, VSP-AM) in 172 adolescents receiving growth hormone."
"The VSP-AM was cross-culturally adapted into English and tested for internal consistency (alpha=0.78-0.89 subscales, 0.74 Summary Score), construct and criterion validity, and responsiveness," explained J.A. Cramer and coauthors at the Yale Veterans Administration Medical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.